# FDA Inspection 1165170 - Daniel V Alfaro, MD - March 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/daniel-v-alfaro-md/5a357093-105d-4ba2-acf7-afb11c3f3308
Source feed: FDA_Inspections

> FDA Inspection 1165170 for Daniel V Alfaro, MD on March 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165170
- Company Name: Daniel V Alfaro, MD
- Inspection Date: 2022-03-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/daniel-v-alfaro-md/8fc77a44-4357-46ca-9d24-faf830246cf5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c